Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

2.56
-0.0700-2.66%
Post-market: 2.580.0200+0.78%19:30 EDT
Volume:3.37M
Turnover:8.75M
Market Cap:281.02M
PE:-15.06
High:2.69
Open:2.59
Low:2.54
Close:2.63
52wk High:5.45
52wk Low:2.42
Shares:109.77M
Float Shares:85.39M
Volume Ratio:1.46
T/O Rate:3.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1700
EPS(LYR):-2.0100
ROE:-4.77%
ROA:-28.42%
PB:0.76
PE(LYR):-1.27

Loading ...

Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2021

Major Issues Report

8-K/A [Amend] - Current report
Nov 04, 2021

Major Issues Report

8-K - Current report
Oct 07, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 31, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 30, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Apr 27, 2021

Major Issues Report

8-K - Current report
Mar 29, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 08, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 07, 2021

Major Issues Report

8-K - Current report